Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
about
Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemiaColony stimulating factors for prevention of chemotherapy induced febrile neutropenia in children with acute lymphoblastic leukaemiaA chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.Improving the outcome for children with cancer: Development of targeted new agents.Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.The use of haemopoietic growth factors in blood disorders.Biological activities of hematopoietic growth factors that lead to future clinical application.Granulocyte-macrophage colony-stimulating factor (GM-CSF) ameliorates chemotherapy-induced neutropenia in children with solid tumors.Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.Granulocyte colony-stimulating factor in neutropenic, pediatric solid tumor patients following chemotherapy.Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children.
P2860
Q24246566-2A726A53-C183-4768-8F39-60C00B830BE6Q24250081-2D1A0525-4688-46FF-86E5-66D560C503CDQ35063075-E1AB62CD-9035-4FA3-B85A-CB6ED5BD0A87Q36238795-55BF0197-9771-4CF9-AD28-C77890C69203Q38039970-04A53A9F-2A08-439A-93B4-08DF9190542CQ40511423-287A5B83-D1E9-4A92-A403-C604317BB2C8Q40630439-F8A6F972-E66B-4CB0-92E8-54CBE8256C35Q40643973-39F6337A-F84D-4472-99AF-095F3065B4EEQ40650546-5D929B69-6D39-4A63-8BA1-2952E8AFE153Q40663684-FC4208CA-8DED-4770-9C3F-2E483723330AQ40668359-30AE6C06-5394-4C46-9B79-E19E7A28F951
P2860
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@ast
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@en
type
label
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@ast
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@en
prefLabel
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@ast
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@en
P2093
P1476
Therapeutic effects and pharma ...... myelosuppressive chemotherapy.
@en
P2093
D L Fairclough
E C Douglass
L C Bowman
V M Santana
W L Furman
W P Petros
P304
P356
10.1200/JCO.1991.9.6.1022
P407
P577
1991-06-01T00:00:00Z